CoChat

Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors

Awad, Mark M., Jones, Robert E., Liu, Hongye, Lizotte, Patrick H., Ivanova, Elena V., Kulkarni, Meghana, Herter-Sprie, Grit S., Liao, Xiaoyun, Santos, Abigail A., Bittinger, Mark A., Keogh, Lauren, Koyama, Shohei, Almonte, Christina, English, Jessie M., Barlow, Julianne, Richards, William G., Barbie, David A., Bass, Adam J., Rodig, Scott J., Hodi, F. Stephen, Wucherpfennig, Kai W., Jänne, Pasi A., Sholl, Lynette M., Hammerman, Peter S., Wong, Kwok-Kin, Bueno, Raphael · 2016 · Cancer Immunology Research
Cited by 73

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

PD-L1 immunohistochemical staining does not always predict whether a cancer will respond to treatment with PD-1 inhibitors. We sought to characterize immune cell infiltrates and the expression of T-cell inhibitor markers in PD-L1–positive and PD-L1–negative malignant pleural mesothelioma samples. We developed a method for immune cell phenotyping using flow cytometry on solid tumors that have been dissociated into single-cell suspensions and applied this technique to analyze 43 resected malignant pleural mesothelioma specimens. Compared with PD-L1–negative tumors, PD-L1–positive tumors had significantly more infiltrating CD45+ immune cells, a significantly higher proportion of infiltrating CD3+ T cells, and a significantly higher percentage of CD3+ cells displaying the activated HLA-DR+/CD38+ phenotype. PD-L1–positive tumors also had a significantly higher proportion of proliferating CD8+ T cells, a higher fraction of FOXP3+/CD4+ Tregs, and increased expression of PD-1 and TIM-3 on CD4+ and CD8+ T cells. Double-positive PD-1+/TIM-3+ CD8+ T cells were more commonly found on PD-L1–positive tumors. Compared with epithelioid tumors, sarcomatoid and biphasic mesothelioma samples were significantly more likely to be PD-L1 positive and showed more infiltration with CD3+ T cells and PD-1+/TIM-3+ CD8+ T cells. Immunologic phenotypes in mesothelioma differ based on PD-L1 status and histologic subtype. Successful incorporation of comprehensive immune profiling by flow cytometry into prospective clinical trials could refine our ability to predict which patients will respond to specific immune checkpoint blockade strategies. Cancer Immunol Res; 4(12); 1038–48. ©2016 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/2326-6066.cir-16-0171

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 73

Metadata

Authors
Awad, M. M., Jones, R. E., Liu, H., Lizotte, P. H., Ivanova, E. V., Kulkarni, M., Herter-Sprie, G. S., Liao, X., Santos, A. A., Bittinger, M. A., Keogh, L., Koyama, S., Almonte, C., English, J. M., Barlow, J., Richards, W. G., Barbie, D. A., Bass, A. J., Rodig, S. J., Hodi, F. S., Wucherpfennig, K. W., Jänne, P. A., Sholl, L. M., Hammerman, P. S., Wong, K.-K., & Bueno, R.
Venue
Cancer Immunology Research
Published
2016-11-30
Volume
4
Issue
12
Pages
1038-1048
ISSN
  • 2326-6066 (ISSN-L)
  • 2326-6074
OpenAlex
W2549354162
Cited by
73
References
14
FWCI
5.10
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors. https://app.cochat.ai/papers/10.1158/2326-6066.cir-16-0171
The paper
Awad, M. M., Jones, R. E., Liu, H., Lizotte, P. H., Ivanova, E. V., Kulkarni, M., Herter-Sprie, G. S., Liao, X., Santos, A. A., Bittinger, M. A., Keogh, L., Koyama, S., Almonte, C., English, J. M., Barlow, J., Richards, W. G., Barbie, D. A., Bass, A. J., Rodig, S. J., . . . Bueno, R. (2016). Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors. Cancer Immunology Research. https://doi.org/10.1158/2326-6066.cir-16-0171

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.